Funding Opportunities


PREMIER has several funding opportunities throughout the year. These grants are intended for projects that are translational in nature with studies focused on advancing precision medicine in rheumatology. Projects related to all types of rheumatologic and/or human autoimmune diseases will be considered. Projects should utilize human samples or show direct links to rheumatologic/autoimmune disease in humans.

All potential applicants should contact us by filling out a Service Request Form after becoming a PREMIER member [ Join Now ].  Please indicate in your message which grant mechanism you are planning to apply for, so that center personnel can assist with your proposal. 

For further questions or comments, please contact or 415-502-3558.


PREMIER funding opportunities:

  1. Resource Allocation Program (RAP). We are sponsoring two different grant mechanisms targeting established ($50,000 maximum) and junior investigators ($40,000 maximum).  For more information, see Pilot Grant for Established Investigators in Basic and Clinical/Translational Sciences or Pilot Grant for Junior Investigators in Basic and Clinical/Translational Sciences.  RAP has two funding cycles per year in the Fall and Spring.


    To submit an application go to:
    You need to have a user account with RAP portal to submit an application. 
           -  We request that all UCSF investigators use their UCSF email account
           -  If you forget your password, click ‘?’ button by the login to reset your password

        Next cycle applications open: Monday, August 21, 2017
        Next submissions deadline: Monday, September 18, 2017 at 2pm PDT
        Next cycle applications open: COMING SOON


  2. Core Usage Grants. These smaller grants ($1,000-$6,000) are managed directly by PREMIER. They  provide funds for investigators’ use of PREMIER Core Services. Projects should seek to advance studies of precision medicine in autoimmune disease and are encouraged to cultivate new collaborations among investigators. Priority will be given to projects that lead established investigators into new directions, or projects involving new or young investigators in studies of precision medicine in autoimmune disease. There will be two application cycles per year, in June and November.

Next cycle applications open: COMING SOON